Effective application of bronchodilator aerosols from metered-dose inhalers (MDI) via resuscitator-bag and adapter

Resuscitation

Volumn 39, Issue 3, 1998, Pages 175-178

  Schleufe, Petra ^a   Reiffen, Hans P ^a   Piepenbrock, Siegfried ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

adrenergic agonist; Asthma; Basic airway management; Inhalation; Resuscitator bag

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; SALBUTAMOL;

AEROSOL; ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHOSPASM; CLINICAL ARTICLE; DRUG DELIVERY SYSTEM; EMERGENCY TREATMENT; HUMAN; INHALATIONAL DRUG ADMINISTRATION; METERED DOSE INHALER; PRIORITY JOURNAL; RESUSCITATION;

ADMINISTRATION, INHALATION; AEROSOLS; AIRWAY RESISTANCE; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; EQUIPMENT DESIGN; FEMALE; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; RESPIRATORY FUNCTION TESTS; RESUSCITATION; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0032459773     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(98)00136-1     Document Type: Article

References (16)

1. [1] Bloomfield P, Carmichael J, Petrie GR, Jewell NP, Crompton GK. Comparison of salbutamol given intravenously and by intermittent positive-pressure breathing in lifethreatening asthma. Br Med J 1979;1:848-50.
2. [2] British Thoracic Society. Guidelines on the Management of Asthma. Thorax 1993;48 (Suppl):1S-24S.
3. [3] Crompton GK. The adult patient' difficulties with inhalers. Lung 1990;168:658-62.
4. [4] Grigg J, Arnon S, Jones T, Clarke A, Silverman M. Delivery of therapeutic aerosols to intubated babies. Arch Dis Child 1992;67:25-30.
5. [5] Htan E, Shalansky KF, Mouat B. Use of metered-dose inhalers in mechanically ventilated patients. Ann Pharmacother 1992;26(10):1247-8.
6. [6] Kim CS, Eldridge MA, Sackner MA. Oropharyngeal deposition and delivery aspects of metered-dose inhaler aerosols. Am Rev Respir Dis 1987;135:157-64.
7. [7] König P. Spacer devices used with metered-dose inhalers-Breakthrough or gimmick? Chest 1985;88:276-84.
8. [8] Nosaka S, Sakai T, Yonekura M, Yoshikawa K. Surfactant for adults with respiratory failure. Lancet 1990;336:947-8.
9. [9] Noseda A, Yernault JC. Sympathomimetics in acute severe asthma: inhaled or parenteral, nebulizer or spacer? Eur Respir J 1989;2:377-82.
10. [10] O'Callaghan C, Dryden S, Cert DN, Gibbin K. Asthma therapy and a tracheostomy. J Laryngeal Otol 1989;103(4):427-8.
11. [11] Sackner MA, Brown LK, Kim CS. Basis of an improved metered aerosol system. Chest 1991;80:915-8.
12. [12] Summer W, Elston R, Tharpe L, Nelson S, Haponik E. Aerosol bronchodilator delivery methods: relative impact on pulmonary function and cost of respiratory care. Arch Int Med 1989;149:618-23.
13. [13] Swedish Society of Chest Medicine. High-dose inhaled versus intravenous salbutamol combined with theophylline in severe acute asthma. Eur Respir J 1990;3:163-70.
14. [14] Tobin MJ, Jenovi G, Danta I, Kim C, Watson H, Sackner MA. Response to bronchodilator drug administration by a new reservoir aerosol delivery system and a review of other auxiliary delivery systems. Am Rev Respir Dis 1982;126:670-5.
15. [15] Turner JR, Corkery KJ, Eckmann D, Gelb AM, Liparsky A, Shepard D. Equivalents of continuous flow nebulizer and metered dose inhaler with reservoir bag for the treatment of acute airway obstruction. Chest 1988;93:476-81.
16. [16] Zapol WM, Rimar S, Gillis N, Marletta M, Bosken CH. Nitric oxide and the lung. Am J Respir Crit Care Med 1994;149(5):1375-80.